flanders.bio, founded in 2004, is the networking organisation for the life sciences sector in Flanders and represents and supports around 350 member companies. The key strategic objectives of flanders.bio are knowledge exchange and valorisation, human capital development, internationalization of the cluster activities and visibility, familiarization of the public with products derived from the sector and the further development of a supportive environment for the members of flanders.bio.
The flanders.bio network brings together companies with activities in the life sciences – companies that are for example developing biopharmaceuticals, medical technologies or agricultural or industrial biotech products. The network also welcomes research institutes, universities and providers of capital, services and technologies to the life sciences community.[citation needed]
Wouter Piepers is the CEO of flanders.bio. Following his appointment in early 2022, Willem Dhooge, previously co-General Manager (with Pascal Engelen), was appointed COO.[1]
Dirk Reyn (Managing Partner Bioqube Factory Fund) is Chairman of the flanders.bio Board of Directors, with Erwin Blomsma (CEO and co-founder at ViroVet) is Vice-Chairman.[2]
See also
- Belgian Society of Biochemistry and Molecular Biology
- BIO.be
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- EuropaBio
- Flanders Institute for Biotechnology (VIB)
- Flanders Investment and Trade
- Flemish institute for technological research (VITO)
- GIMV
- Institute for the promotion of Innovation by Science and Technology (IWT)
- Participatiemaatschappij Vlaanderen
- Pharma.be
- Science and technology in Flanders
References
External links
- flanders.bio
- overview of the flanders.bio members is available on https://flanders.bio/en/member-directory
 | This article related to a non-profit organization is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 24 May 2024, at 08:30